Skip to main content

Table 2 High-throughput methylation analysis of CpG sites per amplicon for the 12 candidate genes

From: Methylation signature of lymph node metastases in breast cancer patients

Genes

Amplicon size (bp)

Total No. of CpG sites in amplicon

No. of analyzed CpG sites in amplicon

No. of analyzed CpG sites per amplicons

Single sites

Composite sites

APC

420

26

11

9

2

BIN1

330

32

12

3

9

BMP6

397

37

26

9

17

BRCA1

413

30

15

10

5

CST6

445

49

19

11

8

ESR-b (ER beta)

374

30

13

6

7

GSTP1

381

23

16

11

5

P14

425

36

22

5

17

P16 (CDKN2A)

580

62

38

12

26

P21 (CDKN1A)

419

30

9

8

1

PTEN

451

34

29

10

19

TIMP3v

441

51

40

12

38

  1. The in silico digestion was performed for the T-cleavage assay. The percentage of total CpG sites in the amplicon is divided into single sites (single CpG sites) and composite sites (two or more adjacent CpG sites fall within one fragment, or when fragment masses are overlapping).